
    
      The study primarily aims to establish desmosine and isodesmosine concentrations in plasma,
      sputum and urine measured as markers of elastin degradation systemically in the lung and also
      markers of inflammation and fibrinogen. Assessment of vital signs, lab tests, carbon monoxide
      diffusing capacity, oxygen saturation, pulmonary function tests, ECGs, physical exams and
      adverse events.
    
  